Financial Services and Asset Management firms operate in an environment of ever increasing regulation and scrutiny, and increasing sophistication in the demands of their clients for products that both maximise return and minimise risk.
Many companies respond to this demand with cumbersome traditional product development approaches, and their only experience of “lean” is narrow, and often inappropriate, “lean six sigma” which fails to deliver substantial benefits.
Avellana Innovation’s team has run successful innovation projects in the heavily regulated pharmaceutical industry for many years, and is exploring with leading Financial Services firms the potential of applying lean innovation to bring the benefits of the Lean Scientific Method to a new industry, and to revolutionise how products and processes are created, improved, and delivered.
Accelerated learning cycles, optimal use of visual management, fast failure, collaborative priority management, and “levelling, flow, and standard work” all have the potential to unlock huge value while dramatically reducing commercial and compliance risk.
Avellana Innovation is the partner of choice for firms in this sector who want to gain an advantage by re-imagining how innovation can make them better.